Four in five users (81%) said prescriber-led, personalized care would improve their journey
While a 5% weight reduction is commonly considered clinically meaningful at the individual level [33], smaller differences between treatments (e.g., 2%) are unlikely to translate into meaningful differences in clinical decision-making and are therefore appropriate for defining equivalence
Whicher CA, Price HC, Phiri P, Rathod S, Barnard-Kelly K, Ngianga K, et al
PubMed laboratory research record [PMID: 34962530] PubMed record related to this compound for laboratory literature review
Biosimilars offer a cheaper option in lieu of branded GLP-1 drugs, making treatments both accessible and affordable for patients